Results 121 to 130 of about 5,449,643 (269)
Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy [PDF]
Christina S. Baik, Keith D. Eaton
openalex +1 more source
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms [PDF]
Mark Borris D. Aldonza +13 more
openalex +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Identifying key outcome domains with underlying specific patient-reported outcomes for psychomotor therapy in mental health care in the Netherlands: a multi-phased qualitative study. [PDF]
de Haan A +3 more
europepmc +1 more source
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy [PDF]
Robert Martinez +7 more
openalex +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source

